Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/diet-and-nutrition-in-dementia-and-cognitive-decline/martin/descriptif_3571008
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3571008

Diet and Nutrition in Dementia and Cognitive Decline

Langue : Anglais

Coordonnateurs : R Martin Colin, Preedy Victor R

Couverture de l’ouvrage Diet and Nutrition in Dementia and Cognitive Decline

Diet and Nutrition in Dementia and Cognitive Decline offers researchers and clinicians a single authoritative source which outlines the complex interrelationships between cognitive decline, dementia and the way diet can be modified to improve outcomes. In a cross-disciplinary field like dementia research and practice, clinicians and researchers need a comprehensive resource which will quickly help them identify a range of nutritional components and how they affect cognitive decline and the development of dementia.

While the focus is on clinical applications, the book also features landmark and innovative preclinical studies that have served as the foundation of rigorous trials. Chapters explore the evidence of how nutritional components, either in the diet or supplements, can either impede the development to, or progression from, the onset of dementia. Authors investigate how conditions and processes overlap between defined conditions and present studies which show that dietary components may be equally effective in a number of conditions characterized by declining cognition or dementia. This book represents essential reading for researchers and practicing clinicians in nutrition, dietetics, geriatrics, nursing, neurology, and psychology, as well as researchers, such as neuroscientists, molecular and cellular biochemists, interested in dementia.

http://www.acnr.co.uk/2015/07/diet-and-nutrition-in-dementia-and-cognitive-decline/

Part 1: Introductory Aspects, Specific Conditions and Basic Mechanisms in Dementia and Cognitive Decline

Part 2: General Aspects, Nutritional Factors and Specific Conditions in Dementia and Cognitive Decline

Part 3: Micronutrients in Dementia and Cognitive Decline

Part 4: Lipids, Amino Acids, Proteins and Alcohol in Dementia and Cognitive Decline

Part 5: Nutraceuticals and Dietary Components in Dementia and Cognitive Decline

Part 6: Practical Issues and Nutritional Health in Dementia and Cognitive Decline

Researchers and practicing clinicians in nutrition, dietetics, geriatrics, neurology, nursing, and psychology, as well as researchers, such as neuroscientists, molecular and cellular biochemists, interested in dementia

Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collabo
  • Explores the complex interrelationships between cognitive decline, dementia and the way diet can be modified to improve outcomes
  • Focuses on both clinical nutrition applications and the innovative preclinical studies that serve as the foundation for rigorous trials
  • Covers specific conditions and mechanisms in dementias, as well as general aspects, risk factors, lifestyle and guidelines for practitioners
  • Organizes chapter content in terms of the molecular, mechanistic, epidemiologic, and practical, so that correlations can be observed across conditions

Date de parution :

Ouvrage de 1260 p.

21.4x27.6 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

236,94 €

Ajouter au panier

Thèmes de Diet and Nutrition in Dementia and Cognitive Decline :

Mots-clés :

1α, 25-dihydroxyvitamin D3, 25-hydroxyvitamin D, A1 receptor, A2A receptor, AMPA receptor trafficking, APOE, Acetoacetate, Acetyl-l-carnitine, Acetylcholine, Acetylcholinesterase inhibitors, Adenosine, Adiposity, Advanced dementia, Adzuki beans, Aging, Alcohol, Alcohol-related brain damage, Alcohol-related dementia, Aluminum, Alzheimer's disease, Alzheimer's, Alzheimer's disease risk, Amino acids, Amyloid β, Amyloid β-protein, Amyloid beta, Amyloid plaques, Amyloid-β, Amyloid-β (Aβ) peptides, Amyotrophic lateral sclerosis, Angelica archangelica, Animal model, Antiamyloidogenic, Antiinflammatory, Antioxidant, Antioxidant supplementation, Antioxidants, Antioxidative activity, ApoEε4, Apoptosis, Ascorbate, Astrocyte, Astrocytic plaques, Ataxia, Atrial fibrillation, Atypical Parkinson's disease, Atypical parkinsonism, Autonomy, B12 intervention, Balint syndrome, Behavioral and psychological symptoms of dementia, Behavioral variant frontotemporal dementia, Beta amyloid, Beta-amyloid, Bioaccumulators, Biomarkers, Blood-brain barrier, Body composition, Body mass index, Body weight, Brain, Brain health, Brain iron deposition, Brain microbleeds, Brain microhemorrhages, Brain-derived neuotrophic factor, Brain-derived neurotrophic factor, C9ORF72, CSF diversion, Caffeine, Caloric restriction, Cancer, Carbohydrates, Carnosinase, Carnosine, Carnosine derivatives, Carotenoids, Catalase, Catechins, Celery, Cerebral amyloidosis, Cerebrospinal fluid, Cerebrovascular disease, Cerebrovascular disorders, Chemistry, Chinese medicine, Cholesterol, Cholinergic dysfunction, Citrus, Clinical study, Clinical trials, Cobalamin, Coffee, Cognition, Cognitive, Cognitive decline, Cognitive deficits, Cognitive disturbance